Additionally, we have recently published that CRISPR/Cas-9 knockout of NSD1, which can be considered as a long-term NSD1 depletion, also demonstrates a cell proliferation decrease in JHU 011 and JHU 022 HNSCC cell lines [27]. This evidence concerns the gene NSD1 and head and neck squamous cell carcinoma.